The committee's recommendation was based on data from the TROPION-Breast01 trial, which also supported the US approval of Datroway in January.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback